Can-Jing Zhang

590 total citations · 1 hit paper
16 papers, 432 citations indexed

About

Can-Jing Zhang is a scholar working on Infectious Diseases, Molecular Biology and Oncology. According to data from OpenAlex, Can-Jing Zhang has authored 16 papers receiving a total of 432 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 5 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Can-Jing Zhang's work include Viral gastroenteritis research and epidemiology (5 papers), Viral Infections and Immunology Research (3 papers) and Hepatitis Viruses Studies and Epidemiology (3 papers). Can-Jing Zhang is often cited by papers focused on Viral gastroenteritis research and epidemiology (5 papers), Viral Infections and Immunology Research (3 papers) and Hepatitis Viruses Studies and Epidemiology (3 papers). Can-Jing Zhang collaborates with scholars based in China, United States and South Korea. Can-Jing Zhang's co-authors include Songmei Wang, Jinhua Xu, Yating Liu, Xiao Liu, Qi Zhang, Xuanyi Wang, Jinxia Wang, Chao Qiu, Xi Jiang and Yudong Jiang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Frontiers in Pharmacology and Journal of Experimental & Clinical Cancer Research.

In The Last Decade

Can-Jing Zhang

16 papers receiving 428 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comprehensive Analysis of Cuproptosis-Related Genes in Immune Infiltration and Prognosis in Melanoma

2022 172 citations Xiao Liu, Yating Liu et al. Frontiers in Pharmacology profile →

Peers

Countries citing papers authored by Can-Jing Zhang

Since Specialization

Citations

This map shows the geographic impact of Can-Jing Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Can-Jing Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Can-Jing Zhang more than expected).

Fields of papers citing papers by Can-Jing Zhang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Can-Jing Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Can-Jing Zhang. The network helps show where Can-Jing Zhang may publish in the future.

Co-authorship network of co-authors of Can-Jing Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Can-Jing Zhang. A scholar is included among the top collaborators of Can-Jing Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Can-Jing Zhang. Can-Jing Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Icaritin inhibits PLK1 to activate DNA damage response in NK/T cell lymphoma and increases sensitivity to GELOX regime 2022 ·Molecular Therapy — Oncolytics ·Can-Jing Zhang, (unknown), (unknown), Lina Chen, Bobin Chen, (unknown), Songmei Wang, Xuanyi Wang	10
2	Comprehensive Analysis of Cuproptosis-Related Genes in Immune Infiltration and Prognosis in Melanoma breakdown → 2022 ·Frontiers in Pharmacology ·(unknown), Xiao Liu, (unknown), Yating Liu, Can-Jing Zhang, Qi Zhang, Jinhua Xu	172
3	Protein Regulator of Cytokinesis 1 (PRC1) Upregulation Promotes Immune Suppression in Liver Hepatocellular Carcinoma 2022 ·Journal of Immunology Research ·Can-Jing Zhang, (unknown), (unknown), Ting Wu, Bobin Chen, Songmei Wang, Xuanyi Wang	5
4	Burden and etiology of moderate and severe diarrhea in children less than 5 years of age living in north and south of China: Prospective, population-based surveillance 2021 ·Gut Pathogens ·(unknown), Theresa K. Bessey, Songmei Wang, Zhaojun Mo, Leslie Barclay, Jinxia Wang, Can-Jing Zhang, Jingchen Ma, Chao Qiu, Gan Zhao, Rongcheng Li, Yuliang Zhao, Baoming Jiang, Xuanyi Wang	10
5	Antitumor effects of icaritin and the molecular mechanisms. 2021 ·PubMed ·Can-Jing Zhang, (unknown), Yudong Jiang, Xuanyi Wang, Songmei Wang	29
6	Resveratrol activates DNA damage response through inhibition of polo-like kinase 1 (PLK1) in natural killer/T cell lymphoma 2020 ·Annals of Translational Medicine ·(unknown), Can-Jing Zhang, Yudong Jiang, (unknown), Chen Xu, Feng Tang, (unknown), (unknown), Songmei Wang, Xuanyi Wang	9
7	Genetic susceptibility to rotavirus infection in Chinese children: a population-based case–control study 2020 ·Human Vaccines & Immunotherapeutics ·Jinxia Wang, Lina Chen, Can-Jing Zhang, (unknown), Yanhong Zhang, Xinjiang Zhang, (unknown), Chao Qiu, Jingchen Ma, Yuliang Zhao, Weiming Zhong, Ming Tan, Xi Jiang, Songmei Wang, Xuanyi Wang	6
8	Burden of viral gastroenteritis in children living in rural China: Population-based surveillance 2019 ·International Journal of Infectious Diseases ·Jinxia Wang, (unknown), Zhaojun Mo, Songmei Wang, (unknown), Yue Li, (unknown), Can-Jing Zhang, Xinjiang Zhang, Jingchen Ma, Chao Qiu, Gan Zhao, Baoming Jiang, Xi Jiang, Rongcheng Li, Yuliang Zhao, Xuanyi Wang	20
9	Glutathione S-transferase A1 suppresses tumor progression and indicates better prognosis of human primary hepatocellular carcinoma 2019 ·Journal of Cancer ·Xiaojia Liu, (unknown), Can-Jing Zhang, (unknown), Yun Bao, Ji Xiong, Zhongwen Zhou, Zhongqing Chen, Chaoqun Wang, Hongguang Zhu, Feng Tang	20
10	Prevalence and distribution of human papillomavirus genotypes in Chinese women between 1991 and 2016: A systematic review 2018 ·Journal of Infection ·(unknown), Wei Zhang, Can-Jing Zhang, Songmei Wang, (unknown), Jinxia Wang, Huan Yang, Xuanyi Wang	41
11	Burden of Viral Gastroenteritis in Children Living in Rural China: Population-Based Surveillance 2018 ·SSRN Electronic Journal ·Jinxia Wang, (unknown), Zhaojun Mo, Songmei Wang, (unknown), Yue Li, (unknown), Xinjiang Zhang, Can-Jing Zhang, Jingchen Ma, Chao Qiu, Gan Zhao, Baoming Jiang, Xi Jiang, Rongcheng Li, Yuliang Zhao, Xuanyi Wang	5
12	Histone deacetylase inhibitor chidamide induces growth inhibition and apoptosis in NK/T lymphoma cells through ATM-Chk2-p53-p21 signalling pathway 2018 ·Investigational New Drugs ·(unknown), Can-Jing Zhang, (unknown), (unknown), Feng Tang, Shuhui Sun, Songmei Wang, (unknown)	29
13	Burden of acute gastroenteritis caused by norovirus in China: A systematic review 2017 ·Journal of Infection ·(unknown), (unknown), Jinxia Wang, Can-Jing Zhang, Chao Qiu, Songmei Wang, Xi Jiang, Xuanyi Wang	50
14	Resveratrol inhibits Extranodal NK/T cell lymphoma through activation of DNA damage response pathway 2017 ·Journal of Experimental & Clinical Cancer Research ·(unknown), Can-Jing Zhang, (unknown), (unknown), Chen Xu, Feng Tang, Xiuling Zhi, (unknown), Songmei Wang, Lianhua Yin	21
15	Plasma Uric Acid is Associated with Postinfarction Cardiac Remodeling in Elderly with Old Myocardial Infarction 2012 ·SHILAP Revista de lepidopterología ·(unknown), Zhihua Wang, (unknown), Can-Jing Zhang	1
16	Up-Regulation of Phosphorylated ATM/ATR Substrate/Akt Expression by Phenylephrine in Peri-Infarct Myocardium in Rats 2011 ·Zhōnghuá mínguó xīnzàngxué huì zázhì ·Yang Mu, Gang Li, Wang Zh, Can-Jing Zhang	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact